The point mutation gamma 2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes.

Source:http://linkedlifedata.com/resource/pubmed/id/20303942

Eur. J. Pharmacol. 2010 Jun 25 636 1-3 18-27

Download in:

View as

General Info

PMID
20303942